Weighted Average Number of Shares Outstanding, Basic of Skye Bioscience, Inc. from Q2 2015 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Skye Bioscience, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2015 to Q3 2025.
  • Skye Bioscience, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 39.7M shares, a 2.18% increase year-over-year.
  • Skye Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 36.5M shares, a 421% increase from 2023.
  • Skye Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 7.01M shares, a 215% increase from 2022.
  • Skye Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2.22M shares, a 99.5% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Skye Bioscience, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 39.7M +847K +2.18% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 39.7M +990K +2.56% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 39.7M +11.7M +41.6% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 36.5M +29.5M +421% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 38.8M +30.9M +393% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 38.7M +34.8M +895% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 28M +24.2M +643% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 7.01M +4.78M +215% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 7.88M +5.9M +297% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 3.89M -492M -99.2% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024
Q1 2023 3.77M -492M -99.2% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 2.22M -404M -99.5% 01 Oct 2022 31 Dec 2022 10-K 22 Mar 2024
Q3 2022 1.98M -412M -99.5% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 496M +117M +31% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 496M +159M +47.2% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 407M +176M +76.2% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 413M +157M +61% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 378M +195M +107% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 337M +155M +84.8% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q4 2020 231M +95.6M +70.7% 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2022
Q3 2020 257M +124M +93% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 183M +50.1M +37.7% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 182M +49.5M +37.3% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 135M +14M +11.6% 01 Oct 2019 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 133M +1.56M +1.18% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 133M +2.25M +1.73% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 133M +44.1M +49.8% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020
Q4 2018 121M +93.2M +334% 01 Oct 2018 31 Dec 2018 10-K 23 Mar 2020
Q3 2018 131M +101M +335% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 131M +102M +360% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 88.6M +65.4M +281% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2018
Q4 2017 27.9M 01 Oct 2017 31 Dec 2017 10-K 19 Mar 2018
Q3 2017 30.2M +10.3M +51.6% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 28.4M +8.46M +42.5% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018
Q1 2017 23.2M 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q3 2016 19.9M 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 19.9M +3.65M +22.4% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q2 2015 16.3M 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2016

Skye Bioscience, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 36.5M +29.5M +421% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 7.01M +4.78M +215% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 2.22M -404M -99.5% 01 Jan 2022 31 Dec 2022 10-K 22 Mar 2024
2021 407M +176M +76.2% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 231M +95.6M +70.7% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022
2019 135M +14M +11.6% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021
2018 121M +93.2M +334% 01 Jan 2018 31 Dec 2018 10-K 23 Mar 2020
2017 27.9M +8.96M +47.3% 01 Jan 2017 31 Dec 2017 10-K 19 Mar 2018
2016 18.9M 01 Jan 2016 31 Dec 2016 10-K 19 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.